×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [3]
THE STATE KEY LA... [3]
Faculty of Healt... [2]
Authors
BIAN YING [3]
Document Type
Journal article [2]
Review article [1]
Date Issued
2023 [1]
2022 [2]
Language
英語English [3]
Source Publication
Frontiers in Pha... [1]
Journal of Clini... [1]
Medicine [1]
Indexed By
SCIE [3]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis
Journal article
Ge, Pu, Han, Chunyan, Reyila, Abudurousuli, Liu, Diyue, Hong, Wenying, Liu, Jiaxin, Zhang, Jinzi, Han, Xiao, Li, Xialei, Huang, Mengjie, Fan, Siyuan, Kaierdebieke, Ayidana, Wu, Xiaoyu, Huang, Xiaolu, Guo, Weirui, Liu, Siyu, Bian, Ying. Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis[J]. Medicine, 2023, 102(35), e34793.
Authors:
Ge, Pu
;
Han, Chunyan
;
Reyila, Abudurousuli
;
Liu, Diyue
;
Hong, Wenying
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
1.3
/
1.6
|
Submit date:2023/09/12
Adverse Events
Aflibercept
Antiangiogenesis
Meta-analysis
Metastatic Colorectal Cancer
Safety
Systematic Review
Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment
Review article
2022
Authors:
Ge, Pu
;
Wan, Ning
;
Han, Xiao
;
Wang, Xinpei
;
Zhang, Jinzi
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
1
IF:
4.4
/
5.0
|
Submit date:2023/01/30
Aflibercept
Cost-effectiveness Analysis
Metastatic Colorectal Cancer
Pharmacoeconomics
Rapid Health Technology Assessment
Targeted Drugs
Efficacy and safety of aflibercept plus chemotherapy in metastatic colorectal cancer: A systematic review and PRISMA-Compliant single-arm Meta-Analysis of noncomparative clinical studies and randomized controlled trials
Journal article
Ge, Pu, Reyila, Abudurosuli, Li, Xin yi, Liu, Si yu, Jiang, Yi xuan, Yang, Ya jie, Li, Xia lei, Bian, Ying. Efficacy and safety of aflibercept plus chemotherapy in metastatic colorectal cancer: A systematic review and PRISMA-Compliant single-arm Meta-Analysis of noncomparative clinical studies and randomized controlled trials[J]. Journal of Clinical Pharmacy and Therapeutics, 2022, 47(6), 713-850.
Authors:
Ge, Pu
;
Reyila, Abudurosuli
;
Li, Xin yi
;
Liu, Si yu
;
Jiang, Yi xuan
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
2.1
/
2.1
|
Submit date:2022/05/17
Aflibercept
Chemotherapy
Colorectal Cancer
Meta-analysis
Systematic Review
Targeted Therapy